DRREDDY — Dr Reddy's Laboratories Balance Sheet
0.000.00%
Last trade - 00:00
- IN₹1.04tn
- IN₹981.87bn
- IN₹246.70bn
- 98
- 27
- 98
- 91
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 24,633 | 25,616 | 34,387 | 44,207 | 61,642 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 51,454 | 60,875 | 61,337 | 78,083 | 87,993 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 111,101 | 125,991 | 145,503 | 177,823 | 204,255 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 53,852 | 52,143 | 56,861 | 61,665 | 66,294 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 224,656 | 232,253 | 266,168 | 297,469 | 322,851 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 58,973 | 72,141 | 81,038 | 97,658 | 85,721 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 84,420 | 76,265 | 89,751 | 105,345 | 89,990 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 140,236 | 155,988 | 176,417 | 192,124 | 232,861 |
Total Liabilities & Shareholders' Equity | 224,656 | 232,253 | 266,168 | 297,469 | 322,851 |
Total Common Shares Outstanding |